The ubiquitin/proteasome system in Epstein–Barr virus latency and associated malignancies
✍ Scribed by Nico P. Dantuma; Maria G. Masucci
- Book ID
- 114340588
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 276 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1044-579X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Expression of different panels of latent gene transcripts is controlled by usage of three distinct Epstein‐Barr virus (EBV) nuclear antigen (EBNA) promoters (Wp, Cp, and Qp). EBV‐associated hemophagocytic syndrome, which is often a fatal disease and generally occurs after primary EBV in
The proto-oncogene c-fgr is expressed at high levels in cell lines derived from lymphomas which are infected with Epstein-Barr virus (EBV) (Cheah eta/., 1986). mRNA extracted directly from biopsies of EBV-infected tissues was analyzed on Northern blots to determine if c-fgr is expressed during lymph
## Abstract EBV‐infected cells and EBV‐associated tumors may evade CTL recognition by defective antigen processing, resulting in poor presentation of CTL epitopes. Since the proteasome is the major source of MHC class I–presented peptides, we analyzed the effect of proteasome inhibitors on the expr